Bellerophon Therapeutics

$6.35
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.28 (-4.22%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell BLPH and other stocks, options, and ETFs commission-free!

About BLPH

Bellerophon Therapeutics, Inc. focuses on developing products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline include PH-ILD, PH-COPD, and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ. The listed name for BLPH is Bellerophon Therapeutics, Inc. Common Stock.

CEO
Fabian Tenenbaum
Employees
18
Headquarters
Warren, New Jersey
Founded
2009
Market Cap
64.31M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
127.12K
High Today
$6.83
Low Today
$6.22
Open Price
$6.51
Volume
119.20K
52 Week High
$26.00
52 Week Low
$3.19

BLPH Earnings

-$0.84
-$0.56
-$0.28
-$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Apr 5, Pre-Market

You May Also Like

XLI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure